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BACKGROUND: Clinicians caring for patients seeking
alcohol detoxification face many challenges, including
lack of evidence-based guidelines for treatment and
high recidivism rates.
OBJECTIVES: To develop a standardized protocol
for determining which alcohol dependent patients
seeking detoxification need inpatient versus outpa-
tient treatment, and to study the protocol’s imple-
mentation.
DESIGN: Review of best evidence by ad hoc task force
and subsequent creation of standardized protocol.
Prospective observational evaluation of initial protocol
implementation.
PARTICIPANTS: Patients presenting for alcohol
detoxification.
INTERVENTION: Development and implementation of a
protocol for evaluation and treatment of patients
requesting alcohol detoxification.
MAIN MEASURES: Number of admissions per month
with primary alcohol related diagnosis (DRG), 30-day
readmission rate, and length of stay, all measured
before and after protocol implementation.
RESULTS: We identified one randomized clinical
trial and three cohort studies to inform the choice
of inpatient versus outpatient detoxification, along
with one prior protocol in this population, and
combined that data with clinical experience to
create an institutional protocol. After implementa-
tion, the average number of alcohol related admis-
sions was 15.9 per month, compared with 18.9 per
month before implementation (p=0.037). There
was no difference in readmission rate or length of
stay.
CONCLUSIONS: Creation and utilization of a protocol
led to standardization of care for patients requesting
detoxification from alcohol. Initial evaluation of pro-
tocol implementation showed a decrease in number
of admissions.
KEY WORDS: alcohol detoxification; alcohol withdrawal; quality
improvement; hospital medicine.
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BACKGROUND
Alcohol dependence is a prevalent and morbid condition. A
recent study estimated a 12-month prevalence of 3.8 % in
the United States.1 Alcohol consumption is the third leading
cause of preventable death in the U.S.2 In 2006, the direct
health care costs in the U.S. were $24 billion, with $5.1
billion due to alcohol-related hospitalizations.
Clinicians caring for patients presenting to emergency
departments in need of detoxification from alcohol must
make difficult decisions, including whether to provide
inpatient versus outpatient treatment. Few randomized
controlled trials compare treatments for alcohol detoxifica-
tion. One study comparing cost and safety of inpatient
versus outpatient detoxification found no difference in
sobriety rates at 6 months, with a significantly lower cost
in the outpatient arm.3
In the absence of clear clinical trial data, strategies for
deciding inpatient versus outpatient detoxification have
utilized severity of withdrawal and clinical predictors of
delirium tremens (DTs).4,5 Predictors of DTs, however, are
generally derived from retrospective studies of hospitalized
medical patients, and may not apply to patients presenting
to the emergency department for detoxification.6,7
The University of North Carolina (UNC) Health Care System
includes a 805-bed academic hospital, with 38,000 admissions
and 73,000 emergency department (ED) visits annually (http://
www.unchealthcare.org/site/aboutus/fiscal_facts.htm). The UNC
internal medicine hospitalist practice admits an average of 19
patients per month for detoxification from alcohol. We have
observed a pattern of short admissions with high frequency of
discharge against medical advice and/or readmissions. Although
we had an inpatient protocol for treatment of alcohol withdrawal,
we lacked a standardized system for determining which patients
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required inpatient detoxification versus those who might be
treated as outpatients.
In this report, we describe our process of creating a
protocol to standardize care for patients presenting to our
ED requesting detoxification. We aimed to determine which
patients could be treated as outpatients and to improve the
coordination with community resources for substance abuse
treatment. We evaluated the effect of the protocol on
admission rates, readmissions, and length of stay.
METHODS
Protocol Development
Task Force and Clinical Questions. We assembled a task
force that included three physicians, one nurse practitioner,
and one case manager. The clinical questions included the
following: 1) Is inpatient or outpatient treatment superior
for alcohol detoxification? 2) What factors should guide
decisions on inpatient versus outpatient treatment?
Literature Search. We searched PubMed (years 1980 to
2011) utilizing combinations of the search terms “alcohol
detoxification,” “inpatient,” “outpatient,” and “ambulatory,”
along with review of reference sources. To identify factors
used to guide decisions on inpatient versus outpatient
treatment, we searched PubMed using the search terms
“delirium tremens” and “alcohol withdrawal”.
Study Selection. We reviewed titles and abstracts, and
pulled the articles that appeared to answer our stated
questions and focused specif ical ly on alcohol
detoxification. Among the pulled articles, we eliminated
those that did not inform our protocol development, and
scanned the reference lists for additional articles. This
review was conducted as a QI project and not as a formal
systematic review. Individual reviewers brought summary
results to task force meetings for group review and
discussion.
Data Synthesis. The task force used the resulting studies to
create the prototype protocol. When there was not direct
clinical trial evidence, the task force used group consensus
for standards of care.4,5,8 In addition, the task force
members included their own clinical experiences with
difficult treatment decisions, such as how to address
acutely inebriated or suicidal patients referred for
admission, in development of the protocol. We resolved
any differences of opinion by consensus.
Protocol Implementation
The prototype protocol was presented for discussion to the
hospitalist and emergency physicians. In our institution, all
referrals for admission for detoxification generate from the
ED. The admitting hospitalist has the discretion to perform
consultation and directly discharge patients from the ED if
appropriate. We sought to create a protocol to standardize
care for both the ED and hospitalist groups, while giving
the hospitalist group a standardized framework for evaluat-
ing those patients referred for admission.
Once all comments were incorporated, the protocol was
implemented on July 1, 2011. We received institutional
review board (IRB) approval for a prospective observational
study of protocol implementation.
Protocol Evaluation
The primary outcome measures were number of admissions
for alcohol detoxification, 30-day readmission rate, and
length of stay. Data were obtained by query of UNC data
submitted to University Healthcare Consortium. Metrics are
available by diagnosis related group (DRG) codes and
physician grouping. We searched the DRGs 896 and 897,
“alcohol/drug abuse or dependence without rehabilitation
therapy,” with and without major comorbidity or complica-
tion (MCC) respectively, coupled with discharge physicians
from our group. In order to identify hospital stays for
observation for alcohol related diagnoses, we searched a
UNC hospital database using specific ICD-9 codes, 291.81,
303.00, 303.81, 303.90, 303.91 and 305.00. These were
narrowed to outpatient visits with attendings from our
hospitalist group. We combined patients on observation
status with those formally admitted to the hospital for our
primary outcome variable labeled hospital admission. We
reviewed the period 21 months after implementation of the
protocol and compared with the period 12 months before
implementation.
We also performed a search of UNC psychiatry admissions
using the same DRGs (896 and 897). Lastly, we measured
number of discharges against medical advice (AMA) for
patients with primary or secondary ICD-9 codes alcohol
detoxification (946.2) or alcohol withdrawal (291.81).
In order to assess adherence to the protocol, we reviewed
the last 20 consecutive admissions after implementation.
We also performed a search of ED visits for the last
3 months of the study period using the same ICD-9 codes
used to identify observation patients. Charts were reviewed
manually to assess whether the protocol was utilized
appropriately.
We plotted the internal medicine admissions per month
on a Shewhart Process Control Chart (C-Chart). After the
first 12 months of data, we calculated control limits and
extended those limits forward to help evaluate for special
cause variation.9
Although control chart analysis was our primary means
of assessing the process, we also performed t-tests to
compare admission rates per month and length of stay
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before and after implementation of the protocol. Analyses
for the t-tests were performed in SPSS (IBM, Armonk,




Literature Review. We identified only one clinical trial
compar ing inpat ient versus outpat ient alcohol
detoxification.3 The trial differs from our clinical setting,
most notably in that after initial detoxification, both groups
were assigned to a structured substance abuse treatment,
which is not a part of standard procedure on most medical
units. The 30-day same cause readmission rate for the
inpatient group was 12.1 %, compared with 8 % outpatient,
despite the average of 9.2 days spent in the inpatient arm.3
The main outcome, cost, was significantly lower in the
outpatient group, and report of sobriety was no different at
6 months.3 While more patients completed detoxification in
the inpatient group, 95 % versus 72 %, there were no
adverse events, including seizures or DTs, in either group.
We identified three studies of predictors of DTs
(Table 1).6,7,10. Two studies are retrospective, utilize
hospitalized medical patients, and have conflicting
results. The rate of DTs reported in these studies is
also substantially higher than average for patients with
alcohol withdrawal. The first study included 200
consecutive internal medicine inpatients treated for
alcohol withdrawal.6 24 % developed DTs, with the
most powerful predictor being concurrent medical
illness. There was no association with prior DTs. In
the second study, 33 % of patients developed DTs; HR>
100 and a history of prior DTs were the strongest
predictor variables.7 The one identified prospective
study examined risk factors for DTs among patients
requesting alcohol detoxification.10 Of these patients,
43.5 % had prior DTs and 41.6 % had prior seizures.10
During the study only 6.9 % of patients developed DTs.
In regression analysis, the strongest predictors were
concurrent infectious disease, HR > 120, and autonomic
signs of withdrawal while legally intoxicated. Prior
seizures and prior DTs were weaker predictors.
We identified only one paper describing a protocol for
the assessment of patients requesting alcohol detoxifica-
tion.5 The authors reported a substantial decrease in
number of admissions for alcohol detoxification after the
protocol was employed. The protocol recommends
inpatient treatment for patients with Clinical Institute
Withdrawal Assessment (CIWA) scores > 15 or for a
history of delirium tremens or alcohol “withdrawal
symptoms.”5 CIWA is clinically validated, widely used
in both inpatient and outpatient health care settings, and
offers the ability to perform continuous assessment of
withdrawal symptoms.11
Evidence Synthesis. Based on our review of the evidence
and the one prior published protocol, we concluded that
patients at highest risk for complicated withdrawal were
those with decompensated acute or chronic medical disease.
These patients would be admitted regardless of CIWA score
(Fig. 1). Although there was not strong evidence to
guide what degree of alcohol withdrawal required
inpatient care, we felt community standard practice
supported admitting patients with CIWA scores > 15
for inpatient detoxification.5,8 Patients with scores 8–15
would be admitted if they had a history of prior seizures
or DTs, but could otherwise be considered for outpatient
detoxification. We felt that patients with CIWA < 8
could be safely treated as outpatients, with the caveat
that prior history of DTs or alcohol withdrawal seizures
should lead to consideration of outpatient detoxification
with fixed dose medications.
Table 1. Summary of Predictors of Delirium Tremens









24 % Concurrent medical
illness (OR 5.1,
CI 2.07-12.55)
> 2 days since last
drink (OR 1.3, CI
1.09-1.61)




33 % Prior DTs (OR 3.9, CI
1.63-9.76)
HR>100 at admission
(OR 4.16, CI 2.03-8.51)
Palmstierna
et al., 2001
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Figure 1. UNC Hospital Medicine protocol for evaluation of patients for alcohol detoxification.
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Our recommended regimens for outpatient detoxification
include two options: benzodiazepines and anticonvulsants.
The standard therapy for alcohol withdrawal is benzodiaz-
epines, with meta-analyses of randomized placebo-con-
trolled trials showing decreased incidence of seizures and
delirium with treatment.8,12 We chose chlordiazepoxide due
to its long half-life and self-tapering effect. Carbamazepine
also has good support by medical evidence and was
included as an option.13,14
We incorporated the requirement for sobriety before
referral for admission. This was based on our experience
with inebriated patients referred for inpatient detoxification,
with a substantial number leaving AMA several hours later
when sober. Similarly, we positioned the assessment for
suicidality only after sobriety had been achieved, having
had a number of admissions driven by concern for suicide
risk based on statements patients made while intoxicated,
only to have the statements recanted when sober. Lastly, in
order to improve coordination with outpatient substance
abuse treatment, we included a process for contacting our
largest local treatment facility directly.
The synthesized protocol includes assessment of risk
factors for complicated withdrawal coupled with CIWA
scores (Fig. 1). This protocol is a summary of the best
evidence as we interpret it, along with our collective clinical
experience.
Protocol Implementation
Modifications. The only modification made to the
prototype protocol related to the assessment of sobriety
in the ED. Our initial draft necessitated a serum alcohol
level of < 0.02 before referral for admission. ED staff
were concerned that re-measuring alcohol levels on
inebriated patients would be unnecessarily time
intensive as they would continue to be cared for in the ED,
and suggested that the requirement be altered to include
clinical assessment of sobriety after the initial alcohol level
was drawn.
Experience with Protocol. After implementation, use of the
protocol was evident by responses received, both internal and
external to our group. As we sought to reduce the admission of
acutely inebriated patients, hospitalist leadership was asked by
ED staff to mediate disagreements over the interpretation of
sobriety. Additionally, as patients were allowed to become sober
in the ED, it became clear that some patients’ primary need was
for psychiatric services. The psychiatry consult service was
asked to take a larger role. As more patients were deemed
appropriate for discharge from the ED, the ED case manager
reported an increased workload. Finally, our largest local
substance abuse treatment center reported increased referrals.
Protocol Evaluation
Outcome Measures. Over the baseline 12-month period
from July 2010 through June 2011, we admitted an average
of 18.9 patients per month for alcohol detoxification.
During this time period the average length of stay was
2.7 days. Readmission rate was 26.5 %.
After intervention, we noted a decrease in the number of
admissions to an average of 15.9 admissions per month.
The C-Chart shown in Fig. 2 demonstrates evidence for a
fundamental change in the process, with 12 out of 14 points
after the new protocol below the center line, meeting a
control chart rule espoused by Grant and Leavenworth.15
We also conducted a t-test comparing number of
admissions per month before and after protocol imple-
mentation, and the difference was statistically significant
(15.9 v. 18.9, p=0.037).
The average length of stay was slightly higher after
introduction of the protocol, but was not statistically
significant (2.7 versus 3.4 days, p=0.09). Readmission rate
was not different (26.5 % to 28.4 %; p=0.33).
Figure 2. Control chart of admissions per month for alcohol related DRGs to UNC Hospital Medicine service. Data shown are for 12 months
before protocol implementation and 21 months after.
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Evaluation of Unintended Consequences. To assess for
patients being prematurely discharged from the ED, we
evaluated all admitted patients to see if they had a
proximate prior ED visit during which they were sent
home. Before the intervention, 8.8 % had an ED visit within
7 days prior to the one that precipitated admission,
compared with 10.8 % after.
The number of admissions to the UNC psychiatry service
with DRGs 896 and 897 did not change. In the 12 months
before protocol implementation, there were 236 admissions
compared with 230 in the following 12 months.
In the 6 months before protocol implementation, there
were 16 AMA discharges with ICD-9 codes of alcohol
withdrawal or alcohol dependence, for an average of 2.7/
month. In the 18 months after protocol implementation,
there were 18, for an average 1.0/month.
Evaluation of Fidelity with the Protocol. Manual chart
review of the last 20 admissions during our observation
period revealed that two admissions were initially for
reasons other than withdrawal or detoxification;
specifically, one case was for altered mental status and
one for seizures. The protocol was followed correctly for
admission in 15 out of 18 cases (83.3 %). Based on this
analysis, we could have potentially avoided three additional
admissions out of 20.
Manual chart review of patients seen in ED for alcohol-
related ICD-9 codes during the last 3 months of the protocol
identified 23 visits that were primarily for alcohol detoxi-
fication but did not lead to an admission. CIWA score was
documented in only eight of these visits, making it hard to
assess for inappropriate discharges, but no discharged
patients had high CIWA scores or clinical description
consistent with severe withdrawal.
Three cases returned to ED for re-evaluation within 48 h
of discharge. One patient returned 1 day after being seen
and was admitted with acute pancreatitis, having reported
no symptoms at the prior visit. One patient returned
intoxicated, was monitored until sober and again
discharged. One patient returned intoxicated with epistaxis
after a physical altercation and was also treated and
released.
DISCUSSION
The development of our protocol has standardized care
for what had been a very challenging issue for our
hospitalist group. Protocol implementation has also
correlated with a decrease in admissions for alcohol-
related DRGs that was statistically significant and
clinically meaningful for the 21 months after initiation.
Average length of stay and 30-day readmission rate did
show an upward trend, possibly due to selection of
more severely ill patients. Regardless, the overall
decrease in average number of admissions by three per
month represents a substantial decrease in utilization of
inpatient resources. In a separate analysis performed by
our group, patients with primary alcohol-related diagnoses
generated costs of $8742 per case. Thus, a decrease of three
admissions per month would generate an annualized cost
decrease of $315,000 per year. While we did not perform a
cost-benefit analysis, this is still likely to represent important
institutional cost savings.
Our manual chart review of the last 20 admissions
revealed reasonable implementation, with 83.3 % following
the protocol. We believe we would have been able to see an
even greater decrease in number of admissions with 100 %
adherence to the protocol. Manual review of ED visits not
admitted for the last 3 months of the study period showed
inconsistent use of CIWA scoring and thus the protocol.
The ED appears to use the CIWA only when a case reaches
its initial threshold for considering admission.
This study adds to the literature on assessment and
treatment of patients presenting for alcohol detoxification.
We have attempted to operationalize current evidence
regarding the risks and benefits of inpatient and outpatient
treatment, in the context of a local care delivery system. We
are unable to provide our patients with the intensive
outpatient treatment program, which included substance
abuse treatment, described by Hayashida and colleagues.3
This is true for many inpatient facilities, creating the need to
stratify risk for complicated withdrawal and to admit some
patients to the hospital.
Our study is similar to that of Asplund and colleagues,
although we provide more detail on implementation of a
protocol and specific rates of hospital admission, length of
stay, and readmissions over time.5 Interestingly, Asplund
and colleagues report almost no admissions to the hospital
after implementation of their protocol,5 while we continue
to have admissions that we deem appropriate. This
difference may reflect differences in medical comorbidity
between their health system and ours.
Our study has several limitations. We do not have a
control group and it is possible that admissions decreased
due to factors unrelated to our intervention. The qualitative
reports of use of the protocol and multiple discussions with
affected groups increase our belief that the protocol led to
decreased hospitalizations. We were also unable to examine
outcomes for patients discharged from the ED based on the
protocol, including any potential adverse events. We are
thus unable to draw definitive conclusions about the
protocol’s safety for patients not admitted to the hospital.
Future evaluations could consider resource use at other
hospitals or EDs, longitudinal use of outpatient facilities,
and long-term sobriety.
Our study demonstrates a standardized approach to patients
requiring alcohol detoxification. Given the widespread and
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common problem of alcohol dependence, there is great
potential for application of similar protocols at other institu-
tions and further study to optimize care for this population.
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